SNCE — Science 37 Holdings Balance Sheet
0.000.00%
- $34.54m
- -$21.87m
- $70.15m
- 35
- 62
- 21
- 32
Annual balance sheet for Science 37 Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Cash and Short Term Investments | 32.5 | 215 | 108 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 11.2 | 10.7 | 11 |
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 46 | 233 | 126 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 2.75 | 3.48 | 0 |
| Net Intangible Assets | |||
| Other Long Term Assets | |||
| Total Assets | 57 | 261 | 126 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 18.3 | 35 | 23.2 |
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | 20.1 | 139 | 29.1 |
| Redeemable Preferred Stock | |||
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Other Equity | |||
| Total Equity | 37 | 122 | 97.4 |
| Total Liabilities & Shareholders' Equity | 57 | 261 | 126 |
| Total Common Shares Outstanding |